176 related articles for article (PubMed ID: 15883282)
1. Cyclosporine vs tacrolimus therapy for posterior and intermediate uveitis.
Murphy CC; Greiner K; Plskova J; Duncan L; Frost NA; Forrester JV; Dick AD
Arch Ophthalmol; 2005 May; 123(5):634-41. PubMed ID: 15883282
[TBL] [Abstract][Full Text] [Related]
2. CD69 expression on peripheral CD4+ T cells parallels disease activity and is reduced by mycophenolate mofetil therapy in uveitis.
Kilmartin DJ; Fletcher ZJ; Almeida JA; Liversidge J; Forrester JV; Dick AD
Invest Ophthalmol Vis Sci; 2001 May; 42(6):1285-92. PubMed ID: 11328741
[TBL] [Abstract][Full Text] [Related]
3. Tacrolimus (FK506) in the treatment of posterior uveitis refractory to cyclosporine.
Sloper CM; Powell RJ; Dua HS
Ophthalmology; 1999 Apr; 106(4):723-8. PubMed ID: 10201592
[TBL] [Abstract][Full Text] [Related]
4. Noninfectious uveitis: a scarcity of randomized clinical trials.
Okada AA
Arch Ophthalmol; 2005 May; 123(5):682-3. PubMed ID: 15883289
[No Abstract] [Full Text] [Related]
5. Interferon-alpha: a key factor in autoimmune disease?
Plskova J; Greiner K; Muckersie E; Duncan L; Forrester JV
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3946-50. PubMed ID: 16936109
[TBL] [Abstract][Full Text] [Related]
6. Validity of using vision-related quality of life as a treatment end point in intermediate and posterior uveitis.
Murphy CC; Greiner K; Plskova J; Frost NA; Forrester JV; Dick AD
Br J Ophthalmol; 2007 Feb; 91(2):154-6. PubMed ID: 16973657
[TBL] [Abstract][Full Text] [Related]
7. Initial evaluation of subcutaneous daclizumab treatments for noninfectious uveitis: a multicenter noncomparative interventional case series.
Nussenblatt RB; Peterson JS; Foster CS; Rao NA; See RF; Letko E; Buggage RR
Ophthalmology; 2005 May; 112(5):764-70. PubMed ID: 15878055
[TBL] [Abstract][Full Text] [Related]
8. Tacrolimus (FK506) in failed cyclosporin A therapy in endogenous posterior uveitis.
Kilmartin DJ; Forrester JV; Dick AD
Ocul Immunol Inflamm; 1998 Jun; 6(2):101-9. PubMed ID: 9689640
[TBL] [Abstract][Full Text] [Related]
9. Neutralizing tumor necrosis factor activity leads to remission in patients with refractory noninfectious posterior uveitis.
Murphy CC; Greiner K; Plskova J; Duncan L; Frost A; Isaacs JD; Rebello P; Waldmann H; Hale G; Forrester JV; Dick AD
Arch Ophthalmol; 2004 Jun; 122(6):845-51. PubMed ID: 15197059
[TBL] [Abstract][Full Text] [Related]
10. Immune monitoring with a lymphocyte adenosine triphosphate assay in kidney transplant recipients treated with a calcineurin inhibitor.
Sugiyama K; Tsukaguchi M; Toyama A; Satoh H; Saito K; Nakagawa Y; Takahashi K; Tanaka S; Onda K; Hirano T
Exp Clin Transplant; 2014 Jun; 12(3):195-9. PubMed ID: 24907718
[TBL] [Abstract][Full Text] [Related]
11. [Efficiency of mycophenolate mofetil in the treatment of intermediate and posterior uveitis].
Greiner K; Varikkara M; Santiago C; Forrester JV
Ophthalmologe; 2002 Sep; 99(9):691-4. PubMed ID: 12219257
[TBL] [Abstract][Full Text] [Related]
12. Cyclosporine versus tacrolimus maintenance therapy in renal transplant.
Alghamdi S; Nabi Z; Skolnik E; Alkorbi L; Albaqumi M
Exp Clin Transplant; 2011 Jun; 9(3):170-4. PubMed ID: 21649564
[TBL] [Abstract][Full Text] [Related]
13. Anti-TNFalpha therapy modulates the phenotype of peripheral blood CD4+ T cells in patients with posterior segment intraocular inflammation.
Greiner K; Murphy CC; Willermain F; Duncan L; Plskova J; Hale G; Isaacs JD; Forrester JV; Dick AD
Invest Ophthalmol Vis Sci; 2004 Jan; 45(1):170-6. PubMed ID: 14691170
[TBL] [Abstract][Full Text] [Related]
14. A randomized trial of tacrolimus versus tacrolimus and prednisone for the maintenance of disease remission in noninfectious uveitis.
Lee RW; Greenwood R; Taylor H; Amer R; Biester S; Heissigerova J; Forrester JV; Dick AD
Ophthalmology; 2012 Jun; 119(6):1223-30. PubMed ID: 22381809
[TBL] [Abstract][Full Text] [Related]
15. Serum cholesterol changes in long-term survivors of liver transplantation: a comparison between cyclosporine and tacrolimus therapy.
Charco R; Cantarell C; Vargas V; Capdevila L; Lázaro JL; Hidalgo E; Murio E; Margarit C
Liver Transpl Surg; 1999 May; 5(3):204-8. PubMed ID: 10226111
[TBL] [Abstract][Full Text] [Related]
16. Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis.
Lowder C; Belfort R; Lightman S; Foster CS; Robinson MR; Schiffman RM; Li XY; Cui H; Whitcup SM;
Arch Ophthalmol; 2011 May; 129(5):545-53. PubMed ID: 21220619
[TBL] [Abstract][Full Text] [Related]
17. Conversion to tacrolimus and atorvastatin in cyclosporine-treated heart transplant recipients with dyslipidemia refractory to fluvastatin.
Skalicka B; Kubanek M; Malek I; Vymetalova Y; Hoskova L; Podzimkova M; Kautzner J
J Heart Lung Transplant; 2009 Jun; 28(6):598-604. PubMed ID: 19481021
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporine therapy for severe sight-threatening uveitis in children and adolescents.
Walton RC; Nussenblatt RB; Whitcup SM
Ophthalmology; 1998 Nov; 105(11):2028-34. PubMed ID: 9818601
[TBL] [Abstract][Full Text] [Related]
19. Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: results of a prospective, randomized international trial in lung transplantation.
Treede H; Glanville AR; Klepetko W; Aboyoun C; Vettorazzi E; Lama R; Bravo C; Knoop C; Aubert JD; Reichenspurner H;
J Heart Lung Transplant; 2012 Aug; 31(8):797-804. PubMed ID: 22554673
[TBL] [Abstract][Full Text] [Related]
20. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
Levy G; Grazi GL; Sanjuan F; Wu Y; Mühlbacher F; Samuel D; Friman S; Jones R; Cantisani G; Villamil F; Cillo U; Clavien PA; Klintmalm G; Otto G; Pollard S; McCormick PA
Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
